ATTO
Attovia Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$25.55
+5.58%Leverage
- Debt / equity
- 0.04x
- Net debt / equity
- -0.25x
- Debt / assets
- 0.03x
- Debt / EBITDA
- -0.07x
- Net debt / EBITDA
- 0.43x
Liquidity & coverage
- Current ratio
- 9.39x
- Quick ratio
- 9.39x
- Cash ratio
- 9.13x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $105.8M
Cash & dividend
- FCF / debt
- -14.22x
- Cash flow / debt
- -13.68x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026